CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare ...

This performance was primarily driven by its Cigna Healthcare segment ... You can also see if CI appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

The subdued stock price reaction suggests that The Cigna Group's (NYSE:CI) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

Analyst firms have responded positively to Cigna’s performance; Raymond James raised its price target for Cigna to $385, maintaining a Strong Buy rating, while Jefferies increased its target to ...

You probably wouldn’t bet on a horse that usually finishes in the middle of the pack. But, in the stock market, sometimes ...

On Friday, UBS analyst AJ Rice confirmed a Buy rating for Cigna (NYSE: CI) shares, maintaining the $390.00 price target.Rice provided insights following a recent investor event at the Evernorth ...

Cigna faces turbulence as proposed Medicaid cuts cast shadows on its financial forecast, despite strong first-quarter ...